Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, on
behalf of its wholly owned subsidiary Cubist Pharmaceuticals, Inc.,
today announced the results of its tender offer (the Convertible
Notes Tender Offer) pursuant to which each holder of Cubists
2.50% Convertible Senior Notes due 2017 (the 2017
Convertible Notes), 1.125% Convertible Senior Notes due 2018
(the 2018 Convertible Notes) and 1.875%
Convertible Senior Notes due 2020 (the 2020
Convertible Notes and together with th
Language:
English
Contact:
MerckMedia:Lainie Keller, (908) 236-5036Steve Cragle, (908) 740-1801orInvestor:Joe Romanelli, (908) 740-1986Justin Holko, (908) 740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more